World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
71
Citations
30608
World Ranking
1802
National Ranking
767

Mark R. Denison publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Mark R. Denison sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 146 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Mark R. Denison D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark R. Denison sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 71 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2011 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Mark R. Denison is affiliated with Vanderbilt University Medical Center in the United States. Their research primarily focuses on medicine, with a significant emphasis on infectious diseases, molecular biology, epidemiology, animal science and zoology, and cardiology and cardiovascular medicine.

The scientist has contributed extensively to the study of viral pathogens, particularly SARS-CoV-2 and COVID-19, with their work spanning various related topics such as COVID-19 clinical research, respiratory viral infections, viral infections and immunology, viral gastroenteritis research, and hepatitis C virus research. The notable topics covered in their research include:

  • SARS-CoV-2 and COVID-19 Research
  • Viral gastroenteritis research and epidemiology
  • Animal Virus Infections Studies
  • COVID-19 Clinical Research Studies
  • Respiratory viral infections research
  • Viral Infections and Immunology Research
  • Hepatitis C virus research

The frequent collaborators of Mark R. Denison are Ralph S. Baric, Laura J. Stevens, Timothy P. Sheahan, Rachel L. Graham, and James D. Chappell, with the number of joint publications ranging from 20 to 33.

Denison's publications appear repeatedly in respected venues such as:

  • UNC Libraries
  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • New England Journal of Medicine
  • Cell Reports

Representative recent papers include:

  • "An mRNA Vaccine against SARS-CoV-2 - Preliminary Report" (2020), published in the New England Journal of Medicine
  • "Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV" (2020), published in Nature Communications
  • "Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults" (2020), published in the New England Journal of Medicine
  • "SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness" (2020), published in Nature
  • "An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice" (2020), published in Science Translational Medicine

Their research contributions have been recognized with awards, including election as a Fellow of the American Association for the Advancement of Science (AAAS) in 2011.

Best Publications

  • An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

    Lisa A. Jackson;Evan J. Anderson;Nadine G. Rouphael;Paul C. Roberts

  • Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.

    Timothy P. Sheahan;Amy C. Sims;Sarah R. Leist;Alexandra Schäfer

  • Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

    Timothy P. Sheahan;Amy C. Sims;Rachel L. Graham;Vineet D. Menachery

  • SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.

    Kizzmekia S. Corbett;Darin K. Edwards;Sarah R. Leist;Olubukola M. Abiona

  • Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.

    Evan J. Anderson;Nadine G. Rouphael;Alicia T. Widge;Lisa A. Jackson

  • Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

    Maria L. Agostini;Erica L. Andres;Amy C Sims;Rachel Lauren Graham

  • Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

    Jesper Pallesen;Nianshuang Wang;Kizzmekia S. Corbett;Daniel Wrapp

  • An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.

    Timothy P. Sheahan;Amy C. Sims;Shuntai Zhou;Rachel L. Graham

  • Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.

    Alicia T. Widge;Nadine G. Rouphael;Lisa A. Jackson;Evan J. Anderson

  • Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.

    I-Chueh Huang;Charles C. Bailey;Jessica L. Weyer;Sheli R. Radoshitzky

  • Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase

    Ariane J. Brown;John J. Won;Rachel L. Graham;Kenneth H. Dinnon

  • Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity.

    Mark R. Denison;Rachel L. Graham;Eric F. Donaldson;Lance D. Eckerle

  • Coronavirus Replication Complex Formation Utilizes Components of Cellular Autophagy

    Erik Prentice;W. Gray Jerome;Tamotsu Yoshimori;Noboru Mizushima

  • Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.

    Andrea J. Pruijssers;Andrea J. Pruijssers;Amelia S. George;Amelia S. George;Alexandra Schäfer;Sarah R. Leist

  • Middle East Respiratory Syndrome

    Yaseen M. Arabi;Hanan H. Balkhy;Frederick G. Hayden;Abderrezak Bouchama

  • Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing.

    Lance D. Eckerle;Michelle M. Becker;Rebecca A. Halpin;Kelvin Li

  • Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics

    Everett Clinton Smith;Hervé Blanc;Marco Vignuzzi;Mark R. Denison

  • Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus

    Boyd Yount;Kristopher M. Curtis;Elizabeth A. Fritz;Lisa E. Hensley

  • Systematic Assembly of a Full-Length Infectious cDNA of Mouse Hepatitis Virus Strain A59

    Boyd Yount;Mark R. Denison;Susan R. Weiss;Ralph S. Baric

  • High Fidelity of Murine Hepatitis Virus Replication Is Decreased in nsp14 Exoribonuclease Mutants

    Lance D. Eckerle;Xiaotao Lu;Steven M. Sperry;Leena Choi

  • Identification and Characterization of Severe Acute Respiratory Syndrome Coronavirus Replicase Proteins

    Erik Prentice;Josephine McAuliffe;Xiaotao Lu;Kanta Subbarao

Frequent Co-Authors

Ralph S. Baric
Ralph S. Baric University of North Carolina at Chapel Hill
James D. Chappell
James D. Chappell Vanderbilt University Medical Center
Amy C. Sims
Amy C. Sims University of North Carolina at Chapel Hill
Timothy P. Sheahan
Timothy P. Sheahan University of North Carolina at Chapel Hill
Susan R. Weiss
Susan R. Weiss University of Pennsylvania
Boyd Yount
Boyd Yount University of North Carolina at Chapel Hill
Barney S. Graham
Barney S. Graham Morehouse School of Medicine
Kizzmekia S. Corbett
Kizzmekia S. Corbett Harvard University
Tomas Cihlar
Tomas Cihlar Gilead Sciences (United States)
Alexandra Schäfer
Alexandra Schäfer Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to various related online degrees and career options. For those interested in healthcare and patient interaction, becoming a child life specialist is a rewarding pathway that combines science with emotional support, often offering competitive salaries.

Students with unique backgrounds or challenges might explore programs highlighted in the best degrees for felons to find flexible, accredited online options that can accommodate diverse circumstances without sacrificing career growth.

For professionals aiming to blend holistic care with clinical practice, functional medicine np programs offer specialized training. These programs focus on integrative approaches to health and can complement a strong biology foundation.

Additionally, those interested in the administrative side of healthcare may pursue credentials like the certified professional coder (cpc) certification. This role plays a crucial part in medical billing and coding, ensuring accurate healthcare data management and reimbursement.

Best Scientists Citing Mark R. Denison

Trending Scientists

Recently Published Articles